Radiofrequency ablation (RFA) as a cytoreductive strategy for hepatic metastasis from breast cancer

Annals of the Royal College of Surgeons of England

Volumn 88, Issue 7, 2006, Pages 639-642

  Lawes, Daniel ^a,b   Chopada, A ^a   Gilliams, A ^a   Lees, W ^a   Taylor, I ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b MAYO CLINIC   (United States)

Author keywords

Breast cancer; Liver metastasis; Radiofrequency ablation (RFA)

Indexed keywords

ANALGESIC AGENT; DICLOFENAC;

ADULT; AGED; ARTICLE; BONE METASTASIS; BREAST CANCER; CANCER SURVIVAL; CERVICAL LYMPHADENOPATHY; CLINICAL ARTICLE; CLINICAL TRIAL; CYTOREDUCTIVE SURGERY; DISEASE ACTIVITY; DISEASE FREE SURVIVAL; FEMALE; FEVER; FOLLOW UP; HUMAN; LIVER METASTASIS; LUNG METASTASIS; LYMPH NODE METASTASIS; MALAISE; MORBIDITY; MORTALITY; OUTCOME ASSESSMENT; PAIN; PLEURA METASTASIS; RADIOFREQUENCY ABLATION; SKIN METASTASIS; TREATMENT FAILURE;

ADULT; AGED; BREAST NEOPLASMS; CATHETER ABLATION; FEMALE; HUMANS; LIVER; LIVER NEOPLASMS; MIDDLE AGED; TREATMENT OUTCOME;

EID: 33751114641     PISSN: 00358843     EISSN: None     Source Type: Journal    
DOI: 10.1308/003588406X149129     Document Type: Article

References (16)

1. Zinser JW, Hortobagyi GN, Buzdar AU, Smith TL, Fraschini G. Clinical course of breast cancer patients with liver metastases. J Clin Oncol 1987; 5: 773-82.
2. Hoe AL, Royle GT, Taylor I. Breast liver metastases- incidence, diagnosis and outcome. J R Soc Med 1991; 84: 714-6.
3. Selzner M, Morse MA, Vredenburgh JJ, Meyers WC, Clavien PA. Liver metastases from breast cancer: long-term survival after curative resection. Surgery 2000; 127: 383-9.
4. Yoshimoto M, Tada T, Saito M, Takahashi K, Uchida Y, Kasumi F. Surgical treatment of hepatic metastases from breast cancer. Breast Cancer Res Treat 2000; 59: 177-84.
5. Seifert JK, Weigel TF, Gonner U, Bottger TC, Junginger T. Liver resection for breast cancer metastases. Hepatogastroenterology 1999; 46: 2935-40.
6. Pocard M, Pouillart P, Asselain B, Salmon R. Hepatic resection in metastatic breast cancer: results and prognostic factors. Eur J Surg Oncol 2000; 26: 155-9.
7. Bathe OF, Kaklamanos IG, Moffat FL, Boggs J, Franceschi D, Livingstone AS. Metastasectomy as a cytoreductive strategy for treatment of isolated pulmonary and hepatic metastases from breast cancer. Surg Oncol 1999; 8: 35-42.
8. Maksan SM, Lehnert T, Bastert G, Herfarth C. Curative liver resection for metastatic breast cancer. Eur J Surg Oncol 2000; 26: 209-12.
9. Curley SA, Izzo F, Delrio P, Ellis LM, Granchi J, Vallone P et al. Radiofrequency ablation of unresectable primary and metastatic hepatic malignancies: results in 123 patients. Ann Surg 1999; 230: 1-8.
10. Solbiati L, Goldberg SN, Ierace T, Livraghi T, Meloni F, Dellanoce M et al. Hepatic metastases: percutaneous radio-frequency ablation with cooled-tip electrodes. Radiology 1997; 205: 367-73.
11. Gregory WM, Smith P, Richards MA, Twelves CJ, Knight RK, Rubens RD. Chemotherapy of advanced breast cancer: outcome and prognostic factors. Br J Cancer 1993; 68: 988-95.
12. Fumoleau P. Treatment of patients with liver metastases. Anticancer Drugs 1996; 7 (Suppl 2): 21-3.
13. Piccart M. Docetaxel: a new defence in the management of breast cancer. Anticancer Drugs 1995; 6 (Suppl 4): 7-11.
14. Elias D, Maisonnette F, Druet-Cabanac M, Ouellet JF, Guinebretiere JM, Spielmann M et al. An attempt to clarify indications for hepatectomy for liver metastases from breast cancer. Am J Surg 2003; 185: 158-64.
15. Raab R, Nussbaum KT, Werner U, Pichlmayr R. Liver metastases in breast carcinoma. Results of partial liver resection. Chirurg 1996; 67: 234-7.
16. Livraghi T, Goldberg SN, Solbiati L, Meloni F, Ierace T, Gazelle GS. Percutaneous radio-frequency ablation of liver metastases from breast cancer: initial experience in 24 patients. Radiology 2001; 220: 145-9.